Search - tctmd.com

Displaying 641 - 660 of 1031

Sort: Relevancy | Date

News Daily News

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

Todd Neale

November 20, 2019

News Conference News AHA 2019

Dapagliflozin Has Benefits Across Heart Failure Subgroups

Todd Neale

November 17, 2019

News Conference News AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Shelley Wood

November 16, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Daily News

As the US Ages, Uptick Seen in Number of Deaths Due to Heart Disease

Caitlin E. Cox

November 04, 2019

News Daily News

Women More Likely Than Men to Develop Heart Failure After STEMI

L.A. McKeown

November 04, 2019

News Daily News

Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis

Michael O'Riordan

October 29, 2019

Presentation TCT Abstracts Posters 2019

The Effect of Prior Percutaneous Coronary Intervention on Pulmonary Artery Systolic Pressure and Ejection Fraction After Transcatheter Aortic Valve Replacement

Presenter: Cecillia Y Wong

October 28, 2019

News Daily News

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

Yael L. Maxwell

October 28, 2019

News Daily News

Repeat Target-Lesion PCI: An Option for Public Reporting?

Michael O'Riordan

October 25, 2019

News Daily News

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

L.A. McKeown

October 21, 2019

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

Presentation TCT 2019

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

Presenter: Joost Daemen

September 27, 2019

Presentation TCT 2019

Hong Kong Presents: TAVR in a Patient With Very Low Ejection Fraction

Presenter: Kam-Tim Chan

September 26, 2019

Presentation TCT 2019

Driving Quality in PCI: The Benefits of Complete Revascularization for Improvements in Ejection Fraction and Patient Quality of Life

Presenter: Ehtisham Mahmud

September 26, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Conference News HFSA 2019

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

L.A. McKeown

September 23, 2019

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

L.A. McKeown

September 18, 2019

Advertisement

VICTORIA Trial of Vericiguat for Worsening HF Meets Primary Endpoint

Dapagliflozin Has Benefits Across Heart Failure Subgroups

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

As the US Ages, Uptick Seen in Number of Deaths Due to Heart Disease

Women More Likely Than Men to Develop Heart Failure After STEMI

Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis

The Effect of Prior Percutaneous Coronary Intervention on Pulmonary Artery Systolic Pressure and Ejection Fraction After Transcatheter Aortic Valve Replacement

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

Repeat Target-Lesion PCI: An Option for Public Reporting?

Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

Hong Kong Presents: TAVR in a Patient With Very Low Ejection Fraction

Driving Quality in PCI: The Benefits of Complete Revascularization for Improvements in Ejection Fraction and Patient Quality of Life

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content